Related Experiment Videos
From Indirect Regulation to Multi-Layered Metabolic Control in MASLD: Multi-Receptor Agonism and
1Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200030, People's Republic of China; Shanghai Medical College of Fudan University, 130 Dongan Road, Shanghai 200030, People's Republic of China.
Pharmacological Research
|August 8, 2026
Summary
Glucagon-like peptide-1 receptor agonists show promise for liver disease but have limitations. A new framework suggests improving treatment by considering systemic regulation, patient factors, and gut microbiota interactions.
Area of Science:
- Hepatology
- Endocrinology
- Metabolic Diseases
Background:
- Glucagon-like peptide-1 receptor agonists (GLP-1RAs) demonstrate efficacy in metabolic dysfunction-associated steatotic liver disease (MASLD).
- Limitations in efficacy are observed in advanced fibrosis, milder metabolic conditions, and upon treatment cessation.
- These limitations highlight the role of regulatory systems beyond pharmacological potency.
Purpose of the Study:
- To propose a multi-layered framework for understanding GLP-1RA efficacy in MASLD.
- To explore how systemic and intrahepatic signaling, metabolic status, and treatment duration influence therapeutic outcomes.
- To investigate the potential of multi-receptor agonists and gut microbiota in overcoming treatment constraints.
Main Methods:
- Conceptual framework development.
- Analysis of regulatory systems influencing GLP-1RA action.
- Discussion of multi-receptor co-activation (GIPR, GCGR) and gut microbiota roles.
- Exploration of cross-intervention convergence in microbiota-associated functions.
Main Results:
- GLP-1RA benefits in MASLD are primarily mediated by indirect, systemic metabolic regulation.
- Therapeutic responses are constrained by signaling network integrity, baseline metabolic severity, and treatment duration.
- Multi-receptor agonists and gut microbiota modulation offer potential strategies to enhance durable responses.
Conclusions:
- A multi-layered regulatory framework is crucial for optimizing GLP-1RA therapy in MASLD.
- Addressing systemic, contextual, and temporal factors is key to overcoming current treatment limitations.
- Targeting the gut microbiota-metabolite axis may reveal novel therapeutic avenues for MASLD.
Related Concept Videos
01:19Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:25Inducible Operons: lac Operon
The lac operon in Escherichia coli is a model for understanding inducible gene regulation and metabolic flexibility. It integrates local control by lactose and global regulation through catabolite repression, enabling E. coli to preferentially metabolize glucose when available and switch to lactose utilization when glucose is scarce.Structure and Function of the lac OperonThe lac operon contains three structural genes: lacZ (β-galactosidase), lacY (lactose permease), and lacA (thiogalactoside...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...